Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:27 pm Purchase |
2025-03-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 8,500,000 8.420% |
1,700,000 (+25.00%) |
Filing History |
| 2025-05-15 3:27 pm Sale |
2025-03-31 | 13G | Enlivex Therapeutics Ltd. ENLV |
Armistice Capital, LLC | 1,781,931 7.530% |
-426,069 (-19.30%) |
Filing History |
| 2025-05-15 3:27 pm Purchase |
2025-03-31 | 13G | Processa Pharmaceuticals, Inc. PCSA |
Armistice Capital, LLC | 578,605 9.990% |
578,605 (New Position) |
Filing History |
| 2025-05-15 3:27 pm Purchase |
2025-03-31 | 13G | Ekso Bionics Holdings, Inc. EKSO |
Armistice Capital, LLC | 13,319 9.990% |
3,319 (+33.19%) |
Filing History |
| 2025-05-15 3:26 pm Purchase |
2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 1,065,076 9.990% |
788,654 (+285.31%) |
Filing History |
| 2025-05-15 3:25 pm Sale |
2025-03-31 | 13G | DANIMER SCIENTIFIC INC DNMRQ |
Armistice Capital, LLC | 89,999 9.990% |
-81,762 (-47.60%) |
Filing History |
| 2025-05-15 3:25 pm Sale |
2025-03-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF |
Armistice Capital, LLC | 473,870 9.990% |
-4,677 (-0.98%) |
Filing History |
| 2025-05-15 3:24 pm Purchase |
2025-03-31 | 13G | Oxbridge Re Holdings Limited OXBR |
Armistice Capital, LLC | 622,165 8.360% |
622,165 (New Position) |
Filing History |
| 2025-05-15 3:24 pm Purchase |
2025-03-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Armistice Capital, LLC | 24,844,725 9.200% |
24,003,030 (+2851.75%) |
Filing History |
| 2025-05-15 3:23 pm Sale |
2025-03-31 | 13G | Cosmos Health Inc. COSM |
Armistice Capital, LLC | 1,917,710 7.030% |
-590,303 (-23.54%) |
Filing History |
| 2025-05-15 3:23 pm Sale |
2025-03-31 | 13G | Wearable Devices Ltd. WLDS |
Armistice Capital, LLC | 73,342 9.990% |
-18,247 (-19.92%) |
Filing History |
| 2025-05-15 3:23 pm Sale |
2025-03-31 | 13G | Accelerate Diagnostics, Inc. AXDX |
Armistice Capital, LLC | 1,879,227 7.450% |
-198,773 (-9.57%) |
Filing History |
| 2025-05-15 3:22 pm Purchase |
2025-03-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,436,000 9.850% |
40,000 (+0.74%) |
Filing History |
| 2025-05-15 3:22 pm Unchanged |
2025-03-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 5,096,251 11.430% |
0 (Unchanged) |
Filing History |
| 2025-05-15 3:22 pm Purchase |
2025-03-31 | 13G | Sphere 3D Corp. ANY |
Armistice Capital, LLC | 2,660,745 9.990% |
77,027 (+2.98%) |
Filing History |
| 2025-05-15 3:21 pm Purchase |
2025-03-31 | 13G | Catheter Precision, Inc. VTAK |
Armistice Capital, LLC | 1,000,849 9.990% |
126,770 (+14.50%) |
Filing History |
| 2025-05-15 3:21 pm Purchase |
2025-03-31 | 13G | MacKenzie Realty Capital, Inc. MKZR |
Armistice Capital, LLC | 1,579,006 9.990% |
1,579,006 (New Position) |
Filing History |
| 2025-05-15 3:20 pm Purchase |
2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Armistice Capital, LLC | 9,235,571 9.990% |
100,754 (+1.10%) |
Filing History |
| 2025-05-15 3:20 pm Purchase |
2025-03-31 | 13G | Medicus Pharma Ltd. Common Stock MDCX |
Armistice Capital, LLC | 1,266,000 9.430% |
1,266,000 (New Position) |
Filing History |
| 2025-05-15 3:20 pm Purchase |
2025-03-31 | 13G | LI-CYCLE HLDGS CORP COM LICYF |
Armistice Capital, LLC | 4,567,108 9.990% |
4,567,108 (New Position) |
Filing History |